Upgrade to SI Premium - Free Trial

Novartis (NVS) Announces Receipt of Positive EMA CHMP Opinion for Afinitor as Grade 1, 2 NET Treatment

April 29, 2016 8:38 AM
Novartis (NYSE: NVS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles